class I recommendation for tamponade, moderate to large effusion not responsive to medical therapy, and suspected bacterial or malignant etiology. 1 Furthermore, the guidelines suggest that pericardiocentesis be performed by experienced operators under fluoroscopic or echocardiographic guidance to decrease the risk of complications.
Recent studies have reported in-hospital outcomes of several cardiac procedures using national databases. These studies not only provide valuable data for the process of informed consent, but also important benchmarks for the quality assessment of the individual centers.
Moreover, identification of the factors associated with worse outcomes may provide an opportunity for quality improvement. The available data on in-hospital outcomes after pericardiocentesis are derived mainly from single center studies, which may be subject to differences in technique and referral bias, among others. These studies have reported very small (<1%) procedure related mortality after pericardiocentesis, but a 30-day-mortality ranging from 8% to 18%. [2] [3] [4] [5] [6] Despite being a commonplace procedure, the in-hospital outcomes of pericardiocentesis at the national level in the United States are not well known. Therefore, we used the national inpatient sample (NIS) database to estimate the inpatient mortality and outcomes of patients undergoing pericardiocentesis. 7 In addition, we aimed to identify independent predictors of in-hospital mortality, particularly the role of hospital procedure volume. Previous studies have shown hospital procedural volume to be an independent predictor of in-hospital outcomes for several cardiac procedures. Finally, there is a continuous increase in percutaneous cardiac procedures associated with iatrogenic pericardial effusion. The inpatient mortality of such patients who require pericardiocentesis is not well described. Therefore, we aimed to evaluate the outcomes of pericardiocentesis for pericardial effusion associated with cardiac procedures.
| METHODS
We obtained the NIS, the largest publicly available all-payer inpatient database sponsored by the Agency for Healthcare Research and Beginning 2012, the NIS approximates 20% stratified sample of discharges from US community hospitals.
For this analysis, hospital visits during which pericardiocentesis was performed, either as the primary (the first procedure field entry) or secondary procedure (2-15 procedure fields entry), were identified using the International Classification of Diseases, Ninth revision (ICD We further characterized each admission for any of the following inpatient procedures-cardiac surgery (except pericardiotomy, pericardiectomy, or pericardial repair), percutaneous coronary intervention (PCI), structural heart interventions (SHI), and electrophysiologic procedures. The ICD9 codes used to identify these procedures are presented in Table S1 -S5 (supplementary appendix). The broad meaningful primary diagnosis and procedures categories were identified using clinical classification software for ICD-CM, a tool developed as a part of the HealthCare Cost and Utilization Project (HCUP). The categories were modified to make them pertinent to our study (Table S6 -S18 in supplementary appendix). The categories with >1% prevalence were presented and used in the analysis. Relevant comorbidities were identified using ICD 9 code as shown in Table S19 -S25 in the supplementary appendix. Furthermore, yearly hospital volume was calculated, and visits were divided into quartiles based on procedure volume. We calculated the time in days from the day of pericardiocentesis to in-hospital death after excluding patients who underwent a surgical pericardial procedure (pericardiotomy, pericardiectomy, or pericardial repair) during the hospitalization.
The study protocol was reviewed and approved by the institutional review board at the Loma Linda University School of Medicine.
| Endpoints
The primary outcome measure was inpatient mortality. Other outcome measures were need for surgical pericardial procedure (pericardiotomy, pericardiectomy, or pericardial repair), length of hospitalization, and time in days from pericardiocentesis to in-hospital death.
| Statistical analysis
We performed a weighted analysis of NIS to compute the national The three most common primary diagnoses were pericardial disease, followed by malignancies and cardiac dysrhythmia. Other categories are shown in Table 1 . Patients with a primary diagnosis of pericardial disorder or pleural disorder were more likely to be stable. All other categories except congestive heart failure, heart valve disorder and pneumonia were more likely to be unstable.
The three most common primary procedures were pericardiocentesis, pericardial surgical procedure (including pericardiotomy, pericardiectomy, and pericardial repair) and electrophysiologic procedures (including pacemaker and implantable defibrillator). Other categories are shown in Table 1 . The patients with primary procedure as pericardiocentesis, diagnostic cardiac catheterization, and incision/drainage of pleura or thoracentesis were more likely to be stable. All other categories except heart valve surgeries were more likely to be unstable.
Malignancy, congestive heart failure and chronic pulmonary disease were the three most common comorbidities (primary or secondary). Other relevant co-morbidities are shown in Table 1 .
Patients with end stage renal disease, coagulopathy, and malignancy were more likely to be unstable.
The in-hospital mortality was 12.30% (11.66-12.96%) and was significantly higher in unstable patients ( Figure 1D ). On the other hand, in-hospital mortality for patients who underwent electrophysiologic procedures was 7.8% (95%CI 6.67-9.31%), significantly lower than controls ( Figure 1B ). The inpatient mortality after diagnostic electrophysiologic, ablation, and pacemaker or defibrillator placement/replacement procedures were 3.5% (1.3-9.0%), 2.3% (1.5-3.55%) and 14.2% ( (Table 3) .
| Hospital procedure volume and mortality
The median yearly hospital procedural volume was 38 (interquartile 
| Independent predictors of in-hospital mortality
The first model included patient demographics and hospital specific variables in addition to hemodynamic instability (Table S26 in supplementary appendix). Age, weekend admission, other race, and unstable status were associated with increased mortality. Whereas, elective admission, private insurance, and hospital procedural volume were associated with lower mortality.
The second model included categories of primary diagnosis (present as a primary or secondary diagnosis) or comorbidities in addition to hemodynamic instability (Table S27 in heart disease, and coagulopathy were associated with increased mortality.
The third model comprises categories of primary procedures and cardiac procedures associated with iatrogenic pericardial effusion. PCI and mechanical ventilation were associated with increased mortality.
Pericardial surgical procedures (pericardiotomy/pericardiectomy/pericardial repair) and electrophysiologic procedures were associated with lower mortality. Other categories were not significantly associated with mortality (Table S28 in supplementary appendix).
The final model included all variables from previous models with a P-value <0.10. Age, Pacific Islander or Asian or other race compared to white, septicemia, malignancy, acute myocardial infarction, respiratory failure, unstable status, and mechanical ventilation were independent predictors of a higher mortality. Elective admission, hospital volume, pericardial disorder, complications of implant/graft, medical or surgical procedure, pleurisy/pleural effusion, thyroid disorder, congestive heart failure, and pericardial surgical procedures were independent predictors of a lower mortality.
| Time from pericardiocentesis to death
The median time in days from pericardiocentesis to death was 2 days (IQR 0-7 days) after excluding patients who underwent a pericardial surgical procedure. Most deaths occurred 2 days or longer after the procedure ( Figure 3A) . However, in the subset of patients which underwent catheter based interventions (ie, PCI, electrophysiologic procedures or structural heart interventions), 58.7% of deaths occurred within 1 day of the pericardiocentesis ( Figure 3B ). In patients without catheter based interventions, 53.8% deaths occurred at 2 days or longer after the pericardiocentesis ( Figure 3C ).
| DISCUSSION
We conducted an analysis of NIS, the largest all-payer inpatient database of the United States, to estimate the incidence of inpatient 
FIGURE 1 Inpatient mortality after pericardiocentesis and coexisting cardiac procedures associated with iatrogenic effusion (A) Percutaneous coronary intervention (PCI) (B) Electrophysiologic procedure (EP) (C) Structural heart interventions (SHI) (D) Cardiac surgery (CTS)
mortality after pericardiocentesis in all-comers, and in the subgroup of patients with cardiac procedures associated with iatrogenic pericardial effusion. Furthermore, we also studied the relationship between the hospital procedure volume and inpatient mortality after pericardiocentesis. To our knowledge, this is the first analysis of its kind of a nationally representative data from the United States.
Foremost, we found that estimated inpatient mortality of patients undergoing pericardiocentesis is significantly higher than previously reported by single center studies. [2] [3] [4] [5] [6] 8, 9 Approximately, one in every six unstable patients undergoing pericardiocentesis died in the hospital, about twice more often compared to the stable patients. Previous single center studies may not have accounted for variability in the outcomes among different centers based on characteristics of the patients, differences in techniques, and resource availability; therefore, they do not provide reliable national estimates. A nationwide population based study of 8101 patients who received pericardiocentesis from Taiwan found an inpatient mortality of 15.6% consistent with our findings. 10 The previous single or multiple center studies have reported procedure related mortality of less than 1% after pericardiocentesis. 2, [4] [5] [6] 8, 9 However, it is interesting to note that these studies reported a 30-day-mortality of 8-18% after the procedure. 2, [4] [5] [6] This suggests that pericardial effusion requiring pericardiocentesis not FIGURE 2 Bar graph showing relationship between quartiles of yearly hospital volume and inpatient mortality after pericardiocentesis FIGURE 3 Pie chart showing distribution days to death after pericardiocentesis for (A) all patients (B) patients with co-existing catheter based cardiac procedures (C) patients without any catheter based cardiac procedure associated with cardiac procedures may actually be a prognostic marker of the associated co-morbidity rather than mechanism of death in many if not all of these patients. There may be several reasons for the high inpatient mortality observed in our study. First, the procedure related mortality may be significantly lower at referral centers, where most previous reported studies originate. Secondly, we found that >50% deaths occurred two or more days after the procedure. As alluded to previously, it suggests that many deaths may be related to the underlying disease process or comorbidities rather than due to unsuccessful pericardiocentesis or its complications. Third, our patient population has some differences compared to prior studies. Our patient population was older and higher proportions of patients were unstable compared to previous studies. 2, 6, 8 Similar to prior studies, about one third of patients had a malignancy. However, the prevalence of percutaneous cardiac procedures in patients undergoing pericardiocentesis has increased significantly and surpasses cardiac surgery. 2, 3, 8 With the continued increase in the use as well as the complexity of percutaneous cardiac procedures, iatrogenic pericardial effusion will likely remain a common etiology for pericardiocentesis. 11 The rapid increase in pericardial pressure due to acute onset, in patients who are usually anticoagulated, is more likely to be associated with hemodynamic collapse and death in the absence of timely intervention compared to chronic large pericardial effusions. Catheter based percutaneous cardiac procedures were performed during the same hospitalization in about 17.77% of patients undergoing pericardiocentesis in our analysis, consistent with a large single center study which reported cardiac perforation as an etiology in 14% patients undergoing pericardiocentesis during 1993-2000. 8 And, most of these catheter based procedures were electrophysiologic procedures consistent with prior studies. 5, 11 As expected, the subgroup of pericardiocentesis patients who underwent PCI and SHI had a significantly higher inpatient mortality compared to controls. About one in four of such patients died during the hospitalization (Figure 1 ), whereas, the contemporary studies of patients with coronary artery perforation during PCI reported an in-hospital mortality of about 4-15.9%. [12] [13] [14] [15] However, it is important to note that only about 11-28.9%
of patients with perforation developed tamponade or significant pericardial effusion requiring pericardiocentesis. Such patients, consistent with our analysis, had significantly higher mortality. 12, 15 Similarly, a single center study reported a mortality of 23.5% in patients with cardiac tamponade during transcatheter aortic valve implantation. 16 Interestingly, we found that despite being commonly unstable, mortality after pericardiocentesis in patients who underwent electrophysiologic procedures was significantly lower than controls. On post hoc analysis, we found that mortality was lower in visits associated with ablation and diagnostic electrophysiologic study. Similar to our analysis, a multicenter survey on the incidence and cause of death after catheter ablation for atrial fibrillation found cardiac tamponade as the most common cause with a fatality rate of 2.3%. 17 The lower mortality is possibly related to the fact that most ablation and diagnostic electrophysiologic procedures are done in patients free of significant comorbidities like septicemia, respiratory failure requiring mechanical ventilation, acute myocardial infarction, and malignancy. Also, the effusion after electrophysiological procedures are mostly associated with perforation of low pressure cardiac chambers as compared to coronary or SHI, and routine intracardiac echocardiography may lead to earlier detection of effusion before hemodynamic instability.
11,18
On the other hand, mortality was not different in visits with pacemaker or defibrillator placement compared to controls. A recent study of NIS from 2008 to 2012 found inpatient mortality of 6.8% in patients with tamponade following pacemaker implantations. 19 However, there are several methodological differences. In this study, visits with primary procedure code for a pacemaker insertion and a diagnostic code for cardiac tamponade were used to select the sample population; visits with a secondary procedure code of pacemaker insertion, lead or pacemaker replacement, defibrillator insertion/replacement or other criteria for hemodynamic instability like hypotension, shock, or use of vasopressors were not included.
Higher hospital procedure volume has been associated with lower mortality for various cardiovascular and non-cardiac surgical procedures. [20] [21] [22] [23] [24] Consistent with previous reports, we found a strong inverse linear relationship between the quartiles of hospital procedure volume and in-hospital mortality ( Figure 2 ). However, the absolute difference in mortality of about 3.19% between the hospitals in the highest and the lowest quartile of yearly volume was only modest compared to some other surgical procedures. 24 Multiple factors like better technique, resource availability, experienced providers, and management of co-morbid conditions are likely an explanation for this trend. However, as opposed to many other surgical procedures which are performed in an elective setting in otherwise stable patients, the majority of patients undergoing pericardiocentesis were unstable.
Therefore, the recommendations by certain groups of selecting high volume centers for surgical procedures may not be applicable to pericardiocentesis. 25 There are several important observations from the multivariable model of independent predictors of mortality after pericardiocentesis.
Expectedly, older age, hemodynamic instability, respiratory failure, and need for mechanical ventilation were associated with higher mortality.
In addition, Asians, pacific islanders or a race other than Hispanic or
Blacks had significantly higher mortality compared to Whites. This may represent a racial disparity rather than a chance finding, and will need to be explored in the future studies. 26 Also, the high risk of in-hospital mortality in acute myocardial infarction with moderate or large pericardial effusion is well known, and is mostly attributed to cardiac rupture. 27 Malignancy was another important predictor of inpatient mortality in ouranalysis. In a study of cancer patients undergoing pericardiocentesis at an academic referral center, the success rate of pericardiocentesis was 99% with no procedure related mortality, but 18% patients died within 1 month of the procedure. 6 On the other hand, we found pericardial disease, thyroid disorder, pleurisy/pleural effusion, and congestive heart failure were associated with lower mortality. This underscores the influence of comorbidities on inpatient mortality after pericardiocentesis. Interestingly, use of the diagnosis code included in the category of complication of surgical or medical procedure or device/implant for the visit (Table S11 and Table S12 in further studies are needed to elicit the causes of high short term mortality in these patients.
CONFLICTS OF INTEREST
None of the authors reported any conflict of interest related to this manuscript.
